Literature DB >> 16973105

Mechanisms of pathologic new bone formation.

Kurt de Vlam1, Rik J U Lories, Frank P Luyten.   

Abstract

Pathologic new bone formation occurs in response to a variety of stimuli. Heterotopic and orthotopic bone formation can interfere with the normal function of the joint and can contribute to disability in inflammatory joint diseases. Syndesmophyte formation and progressive ankylosis are characteristic features of spondyloarthropathies, including psoriatic arthritis and ankylosing spondylitis, and they can be regarded as abnormal bone remodeling. Successful blocking of inflammation in patients with spondyloarthropathy apparently fails to halt progression of ankylosis in cohort studies. This suggests that though they may be linked in some way, bone formation and inflammation are largely independent phenomena. Indeed, new bone formation also occurs in diseases such as osteoarthritis and diffuse idiopathic skeletal hyperostosis. Therefore, therapeutic strategies in spondyloarthropathy ideally should control both inflammation and bone formation.

Entities:  

Mesh:

Year:  2006        PMID: 16973105     DOI: 10.1007/s11926-006-0061-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  50 in total

1.  Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis.

Authors:  R J U Lories; P Matthys; K de Vlam; I Derese; F P Luyten
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

2.  Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis.

Authors:  Rik J U Lories; Melina Daans; Inge Derese; Patrick Matthys; Ahmad Kasran; Przemko Tylzanowski; Jan L Ceuppens; Frank P Luyten
Journal:  Arthritis Rheum       Date:  2006-06

3.  Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2.

Authors:  E Zelzer; D J Glotzer; C Hartmann; D Thomas; N Fukai; S Soker; B R Olsen
Journal:  Mech Dev       Date:  2001-08       Impact factor: 1.882

4.  A method to score radiographic change in psoriatic arthritis.

Authors:  S Wassenberg; V Fischer-Kahle; G Herborn; R Rau
Journal:  Z Rheumatol       Date:  2001-06       Impact factor: 1.372

Review 5.  The control of chondrogenesis.

Authors:  Mary B Goldring; Kaneyuki Tsuchimochi; Kosei Ijiri
Journal:  J Cell Biochem       Date:  2006-01-01       Impact factor: 4.429

6.  Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis.

Authors:  R J François; D L Gardner; E J Degrave; E G Bywaters
Journal:  Arthritis Rheum       Date:  2000-09

7.  Spinal entheseal new bone formation: the early changes of spinal diffuse idiopathic skeletal hyperostosis.

Authors:  V L Fornasier; G Littlejohn; M B Urowitz; E C Keystone; H A Smythe
Journal:  J Rheumatol       Date:  1983-12       Impact factor: 4.666

8.  Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study.

Authors:  Maria-Antonietta D'Agostino; Roula Said-Nahal; Cécile Hacquard-Bouder; Jean-Louis Brasseur; Maxime Dougados; Maxime Breban
Journal:  Arthritis Rheum       Date:  2003-02

9.  Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.

Authors:  Rik J U Lories; Inge Derese; Jan L Ceuppens; Frank P Luyten
Journal:  Arthritis Rheum       Date:  2003-10

10.  Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Authors:  Christopher T Ritchlin; Sally A Haas-Smith; Ping Li; David G Hicks; Edward M Schwarz
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

View more
  10 in total

Review 1.  Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics.

Authors:  Heiner Appel; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

2.  Remission in psoriatic arthritis.

Authors:  Kurt de Vlam; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

3.  Contributions of muscle-resident progenitor cells to homeostasis and disease.

Authors:  Devaveena Dey; David J Goldhamer; Paul B Yu
Journal:  Curr Mol Biol Rep       Date:  2015-10-10

4.  Glast-expressing progenitor cells contribute to heterotopic ossification.

Authors:  Lixin Kan; Chian-Yu Peng; Tammy L McGuire; John A Kessler
Journal:  Bone       Date:  2012-12-20       Impact factor: 4.398

5.  Effects of time of initial exposure to MSV sarcoma on bone induction by dentine matrix implants and on orthotopic femora.

Authors:  Krzysztof Włodarski; Paweł Włodarski; Ryszard Galus; Aniela Brodzikowska
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

6.  Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis.

Authors:  Xiaotian Chang; Jinxiang Han; Yan Zhao; Xinfeng Yan; Shui Sun; Yazhou Cui
Journal:  BMC Musculoskelet Disord       Date:  2010-12-08       Impact factor: 2.362

Review 7.  Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis.

Authors:  Tobias Braun; Jochen Zwerina
Journal:  Arthritis Res Ther       Date:  2011-07-28       Impact factor: 5.156

Review 8.  Bone morphogenetic proteins in destructive and remodeling arthritis.

Authors:  Rik J U Lories; Frank P Luyten
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

9.  Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis.

Authors:  Fenli Shao; Qianqian Liu; Yuyu Zhu; Zhidan Fan; Wenjun Chen; Shijia Liu; Xiaohui Li; Wenjie Guo; Gen-Sheng Feng; Haiguo Yu; Qiang Xu; Yang Sun
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

Review 10.  Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis.

Authors:  Rik J U Lories; Frank P Luyten; Kurt de Vlam
Journal:  Arthritis Res Ther       Date:  2009-04-27       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.